BN vs. JNJ
BN (Brookfield Corporation) and JNJ (Johnson & Johnson) are both stocks. BN operates in Asset Management (Financial Services), while JNJ operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, BN returned 15.61%/yr vs 10.46%/yr for JNJ. At a 0.20 correlation, their price movements are largely independent.
Performance
BN vs. JNJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BN achieves a -1.31% return, which is significantly lower than JNJ's 17.68% return. Over the past 10 years, BN has outperformed JNJ with an annualized return of 15.61%, while JNJ has yielded a comparatively lower 10.46% annualized return.
BN
- 1D
- 0.40%
- 1M
- 0.27%
- YTD
- -1.31%
- 6M
- -0.68%
- 1Y
- 15.16%
- 3Y*
- 28.32%
- 5Y*
- 12.10%
- 10Y*
- 15.61%
JNJ
- 1D
- 1.07%
- 1M
- 5.14%
- YTD
- 17.68%
- 6M
- 15.11%
- 1Y
- 57.60%
- 3Y*
- 17.82%
- 5Y*
- 10.94%
- 10Y*
- 10.46%
BN vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BN Brookfield Corporation | -1.31% | 20.54% | 44.18% | 28.60% | -34.80% | 49.30% | 8.99% | 52.68% | -10.65% | 33.82% |
JNJ Johnson & Johnson | 17.68% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 10.82% | 16.22% | -5.13% | 24.43% |
Correlation
The correlation between BN and JNJ is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Dec 30, 1983 | 0.20 |
The correlation between BN and JNJ shifts across timeframes, from -0.01 (1 year) to 0.22 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
BN:
$107.01B
JNJ:
$588.98B
BN:
$0.56
JNJ:
$8.65
BN:
80.05
JNJ:
27.85
BN:
175.42
JNJ:
0.93
BN:
1.40
JNJ:
6.08
BN:
2.50
JNJ:
7.25
BN:
$76.58B
JNJ:
$96.36B
BN:
$27.02B
JNJ:
$66.60B
BN:
$31.07B
JNJ:
$31.62B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BN vs. JNJ — Risk / Return Rank
BN
JNJ
BN vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Brookfield Corporation (BN) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BN | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.89 | ||
| Sortino ratioReturn per unit of downside risk | -4.03 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.61 | -0.50 |
| Calmar ratioReturn relative to maximum drawdown | 0.69 | 5.28 | -4.59 |
| Martin ratioReturn relative to average drawdown | 1.90 | 15.52 | -13.62 |
Loading charts...
Drawdowns
BN vs. JNJ - Drawdown Comparison
The maximum BN drawdown since its inception was -82.22%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for BN and JNJ.
Loading charts...
Drawdown Indicators
| BN | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.22% | -50.67% | -31.55% |
Max Drawdown (1Y)Largest decline over 1 year | -22.05% | -10.96% | -11.09% |
Max Drawdown (3Y)Largest decline over 3 years | -27.84% | -15.95% | -11.89% |
Max Drawdown (5Y)Largest decline over 5 years | -41.85% | -18.41% | -23.44% |
Max Drawdown (10Y)Largest decline over 10 years | -51.42% | -27.37% | -24.05% |
Current DrawdownCurrent decline from peak | -7.89% | -2.54% | -5.35% |
Average DrawdownAverage peak-to-trough decline | -28.51% | -11.90% | -16.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.99% | 3.72% | +4.27% |
Volatility
BN vs. JNJ - Volatility Comparison
Brookfield Corporation (BN) has a higher volatility of 10.05% compared to Johnson & Johnson (JNJ) at 5.47%. This indicates that BN's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BN | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.05% | 5.47% | +4.58% |
Volatility (6M)Calculated over the trailing 6-month period | 22.60% | 12.16% | +10.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.82% | 16.94% | +11.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.27% | 16.87% | +14.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.17% | 18.48% | +11.69% |
Dividends
BN vs. JNJ - Dividend Comparison
BN's dividend yield for the trailing twelve months is around 0.55%, less than JNJ's 2.18% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BN Brookfield Corporation | 0.55% | 0.52% | 0.56% | 0.70% | 1.44% | 1.12% | 1.55% | 1.11% | 1.56% | 1.29% | 1.58% | 1.50% |
JNJ Johnson & Johnson | 2.18% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
Financials
BN vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Brookfield Corporation and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BN vs. JNJ - Profitability Comparison
BN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Brookfield Corporation reported a gross profit of 4.43B and revenue of 18.39B. Therefore, the gross margin over that period was 24.1%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
BN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Brookfield Corporation reported an operating income of 4.39B and revenue of 18.39B, resulting in an operating margin of 23.9%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
BN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Brookfield Corporation reported a net income of 100.59M and revenue of 18.39B, resulting in a net margin of 0.6%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
Frequently Asked Questions
BN and JNJ have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BN has higher volatility (10.05%) compared to JNJ (5.47%). In terms of maximum drawdown, BN dropped -82.22% vs JNJ's -50.67%.
JNJ currently has the higher Sharpe Ratio (3.42 vs 0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BN and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer